Navigation Links
MUSC's Hollings Cancer Center Dedicates Edwin and Barbara Pearlstine Healing Garden Endowed with $1 Million Gift from Edwin S. Pearlstine, Jr.
Date:4/16/2008

Ceremony Also Celebrates Opening of Hollings Expanded Building

CHARLESTON, S.C., April 16 /PRNewswire/ -- The Medical University of South Carolina's Hollings Cancer Center has dedicated the Edwin and Barbara Pearlstine Healing Garden. The healing garden, designed by Robert Chesnut, was endowed with a $1 million gift from Edwin S. Pearlstine, Jr., in memory of his wife of 40 years, Barbara Langer Pearlstine, who died of cancer in 1997.

"Edwin and Barbara Pearlstine will forever be known in this city and at MUSC as true exemplars of philanthropy," said MUSC President Ray Greenberg, M.D., Ph.D. "We are thankful to Edwin Pearlstine for this incredibly generous gift in memory of Barbara. This garden will provide special comfort to our patients for many years to come."

"It is a privilege to recognize this generous gift from Edwin Pearlstine in memory of his wife, Barbara," said Hollings Cancer Center Director Andrew S. Kraft, M.D. "HCC endeavors every day to provide our patients with the very best in cancer care and therapies. We hope that in the beauty of this garden, they will be able to find an added measure of healing and solace."

Mr. Pearlstine, a Charleston native, has made his mark on the city many times over with his business acumen and philanthropy. Under his leadership, the family business, Pearlstine Distributors, became one of the largest privately-owned businesses in the region. He also is part owner of the South Carolina Stingrays. In 2002, MUSC awarded Mr. Pearlstine the honorary degree of Doctor of Humane Letters; and he is a member of the MUSC Society of 1824 for his gift creating the healing garden.

"I know that patients and their families are going through a terrible ordeal," Edwin S. Pearlstine, Jr., said. "If the Healing Garden can give them some comfort it will be well worth my commitment."

About Hollings Cancer Center

Hollings Cancer Center at the Medical University of South Carolina offers state-of-the-art diagnostic capabilities, therapies and surgical techniques and has multidisciplinary clinics that involve surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and many other specialists seeing patients under one roof. Multidisciplinary care is provided in disease specific clinics such as thoracic, breast, head & neck, genitourinary, gastrointestinal, hematological, and pediatric cancers. Hollings Cancer Center is the largest academic-based cancer program in South Carolina. The Hollings Cancer Center is currently a developing National Cancer Institute designated cancer center and has more than $35M in cancer research funding. More than 1,000 people are currently participating on a cancer clinical trial at HCC. For more information, please visit http://www.hcc.musc.edu .

About MUSC

Founded in 1824 in Charleston, The Medical University of South Carolina is the oldest medical school in the South. Today, MUSC continues the tradition of excellence in education, research, and patient care. MUSC educates and trains more than 3,000 students and residents, and has nearly 11,000 employees, including 1,500 faculty members. As the largest non-federal employer in Charleston, the university and its affiliates have collective annual budgets in excess of $1.6 billion. MUSC operates a 750-bed medical center, which includes a nationally recognized Children's Hospital and a leading Institute of Psychiatry. For more information on academic information or clinical services, visit http://www.musc.edu or http://www.muschealth.com .


'/>"/>
SOURCE The Medical University of South Carolina
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. Novel Technology Breaks Through Cancer Pain
9. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
10. Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... ... the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency Miami, January 24-26). ... to examine vital clinical research issues such as trial performance metrics, patient enrollment ...
(Date:1/18/2017)... ... , ... Thirty-six startup companies in University City and Center City have been ... Economic Development in 2016 as part of the Keystone Innovation Zone (KIZ) Tax Credit ... and represent the highest number of awards to the largest number of companies in ...
(Date:1/18/2017)... Texas , Jan. 18, 2017  Caris ... and the Lustgarten Foundation, the largest private funder ... a clinical trial evaluating the impact of immunotherapy ... providing clinical trial enrollment services to identify potential ... facilitate communication between treating physicians and study investigators. ...
(Date:1/17/2017)... ... January 17, 2017 , ... LGC ... to its VALIDATE® SP2 calibration verification / linearity test kit. VALIDATE® SP2 evaluates ... Each VALIDATE® SP2 kit is prepared using the CLSI recommended “equal delta” method ...
Breaking Biology Technology:
(Date:12/15/2016)... DUBLIN , Dec 15, 2016 ... Research and Markets has announced ... to their offering. The report forecasts the global military ... 2016-2020. The report has been prepared based on an ... market landscape and its growth prospects over the coming years. The report ...
(Date:12/15/2016)... Dec. 15, 2016  There is much more to ... starting the engine. Continental will demonstrate the intelligence of ... Vegas . Through the combination of the keyless ... and biometric elements, the international technology company is opening ... and authentication. "The integration of biometric elements ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at Trinity ... for graphene by combining the material with Silly ... sensitive pressure detector able to sense pulse, blood ... small spider.  The research team,s ... be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):